scorecardresearch
Thursday, April 25, 2024
Support Our Journalism
HomeIndiaGovernanceSupreme Court ends case against US-based pharma J&J for faulty hip implants

Supreme Court ends case against US-based pharma J&J for faulty hip implants

Follow Us :
Text Size:

The Centre has formulated a scheme to ensure compensation upto Rs 1.22 crore to patients with the faulty hip implants. 

New Delhi: The Supreme Court Friday closed the case seeking action against US-based pharma major Johnson and Johnson for implanting faulty hip implants into patients here, saying that steps have been taken by the Centre to provide compensation upto Rs 1.22 crore to them.

A bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Union Health Ministry which said that a compensation scheme has been formulated by it to ensure proper compensation to the victims of faulty hip implants.

Disposing of the PIL filed by one Arun Goenka, the top court asked the Centre to widely publicise its compensation scheme to ensure that all the victims of such implants seek help for their grievances.

Earlier, the Centre had informed the apex court that the report of its panel on alleged “faulty” hip implants, made by the pharma major was ready and would be filed within a week.

The PIL had alleged that “faulty” and “deadly” hip implants have been fitted into the bodies of 4,525 Indian patients who had undergone the replacement surgeries since 2005. – PTI

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular